Recombinant multi-species CXCL14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This antimicrobial gene belongs to the cytokine gene family which encode secreted proteins involved in immunoregulatory and inflammatory processes. The protein encoded by this gene is structurally related to the CXC (Cys-X-Cys) subfamily of cytokines. Members of this subfamily are characterized by two cysteines separated by a single amino acid. This cytokine displays chemotactic activity for monocytes but not for lymphocytes, dendritic cells, neutrophils or macrophages. It has been implicated that this cytokine is involved in the homeostasis of monocyte-derived macrophages rather than in inflammation. [provided by RefSeq, Sep 2014]
The Alternative Names of target: 1110031L23Rik,1200006I23Rik,BMAC,BRAK,C-X-C motif chemokine 14,CXCL14,Chemokine BRAK,Cxcl14,KEC,KS1,Kec,MIP-2G,MIP-2g,MIP2G,MIP2gamma,NJAC,SCYB14,Scyb14,Small-inducible cytokine B14,bolekine

Target products collectionGo to CXCL14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0135-Ag-1/ GM-Tg-hg-SE0135-Ag-2 Human CXCL14 protein Human
GM-Tg-rg-SE0135-Ag-1/ GM-Tg-rg-SE0135-Ag-2 Rat CXCL14 protein Rat
GM-Tg-mg-SE0135-Ag-1/ GM-Tg-mg-SE0135-Ag-2 Mouse CXCL14 protein Mouse
GM-Tg-cynog-SE0135-Ag-1/ GM-Tg-cynog-SE0135-Ag-2 Cynomolgus/Rhesus macaque CXCL14 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0135-Ag-1/ GM-Tg-felg-SE0135-Ag-2 Feline CXCL14 protein Feline
GM-Tg-cang-SE0135-Ag-1/ GM-Tg-cang-SE0135-Ag-2 Canine CXCL14 protein Canine
GM-Tg-bovg-SE0135-Ag-1/ GM-Tg-bovg-SE0135-Ag-2 Bovine CXCL14 protein Bovine
GM-Tg-equg-SE0135-Ag-1/ GM-Tg-equg-SE0135-Ag-2 Equine CXCL14 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0135-Ag-1/ GM-Tg-hg-SE0135-Ag-2; GM-Tg-rg-SE0135-Ag-1/ GM-Tg-rg-SE0135-Ag-2;
GM-Tg-mg-SE0135-Ag-1/ GM-Tg-mg-SE0135-Ag-2; GM-Tg-cynog-SE0135-Ag-1/ GM-Tg-cynog-SE0135-Ag-2;
GM-Tg-felg-SE0135-Ag-1/ GM-Tg-felg-SE0135-Ag-2; GM-Tg-cang-SE0135-Ag-1/ GM-Tg-cang-SE0135-Ag-2;
GM-Tg-bovg-SE0135-Ag-1/ GM-Tg-bovg-SE0135-Ag-2; GM-Tg-equg-SE0135-Ag-1/ GM-Tg-equg-SE0135-Ag-2
Products Name CXCL14 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CXCL14
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CXCL14 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.